Huo et al. reported that silencing of ISG15 increased cisplatin resistance in colorectal cancer A549 cells by the increase of p53 stability [21], which is consistent with our findings of a down-regulation of ISG15 and up-regulation of p53 in PANC-1R cells. This evidence concerns the gene ISG15 and colorectal cancer.